Natera advances molecular diagnostics with integrity and scientific rigor, and supports integration of information provided by our tests into health care decision making. Their tests are clinically validated in over 100 peer-reviewed publications with over 1.3 million patients studied.
Natera participated in the largest prospective studies to date in molecular diagnostics in oncology, women’s health, and organ health. They meet or exceed applicable industry and regulatory standards for all of our tests to deliver high-quality results, and have processed over 5 million tests in our CAP/CLIA‑certified labs.
They have more than 150 medical professionals on staff who provide expert support to help make their test results clear and easy to understand.